DENGVAXIA
INJ PLQ SUS ISP 1+1X0,5ML ISP+2J
| SÚKL code | 0238293 |
|---|---|
| Name of the product | DENGVAXIA |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | DENGVAXIA |
| Supplement | INJ PLQ SUS ISP 1+1X0,5ML ISP+2J |
| Strenght | |
| Pharmaceutical form | Powder and solvent for suspension for injection in prefilled syringe |
| Package | 1+1X0,5ML ISP+2J |
| Route | Subcutaneous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
LIVE ATTENUATED CHIMERIC YELLOW FEVER DENGUE (VIRUS CHIMERICUS FAEBRIS FLAVAE DENGUAE SERO) LIVE ATTENUATED CHIMERIC YELLOW FEVER DENGUE (VIRUS CHIMERICUS FAEBRIS FLAVAE DENGUAE SERO) LIVE ATTENUATED CHIMERIC YELLOW FEVER DENGUE (VIRUS CHIMERICUS FAEBRIS FLAVAE DENGUAE SERO) LIVE ATTENUATED CHIMERIC YELLOW FEVER DENGUE (VIRUS CHIMERICUS FAEBRIS FLAVAE DENGUAE SERO) |
| ATC group | J07BX04 |
| ATC group name | VAKCÍNY PROTI INFEKCÍM VYVOLANÝM VIREM DENGUE |
Marketing authorisation information
| Registration Number | EU/1/18/1338/001 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Sanofi Pasteur, Lyon |
| MA Holder country | FRANCIE |
cz